HSPA1A and retinitis pigmentosa: They also suggested that HSP70 expression inducers, such as valproic acid or geranylgeranylacetone (GGA), could be candidate therapeutic agents for the prevention of retinal degenerative diseases, including retinitis pigmentosa.